EXEL
Exelixis, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #854
- Final score
- 24.45
- Years on list
- 7
↘ Down 242 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 242 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 140 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | EXEL | BRKR | BBIO |
|---|---|---|---|
| Climate Change | 27.0 | 28.0 | 19.8 |
| Employee Relations | 33.6 | 19.3 | 28.0 |
| Environment | 18.4 | 23.7 | 7.4 |
| Stakeholders & Society | 19.3 | 22.6 | 14.5 |
| Human Rights | 4.7 | 32.7 | 11.8 |
| Governance | 28.5 | 27.1 | 25.9 |
| Performance Rating | 52.0 | 37.9 | 29.0 |